Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: An open-label study

BMC Geriatrics

Volumn 4, Issue , 2004, Pages

  Wohlreich, Madelaine M ^a   Mallinckrodt, Craig H ^a   Watkin, John G ^a   Hay, Donald P ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE;

ABDOMINAL PAIN; ADULT; AGED; AGITATION; ANGINA PECTORIS; ANOREXIA; ANXIETY; ARTICLE; ATHEROSCLEROSIS; BACKACHE; BLOOD PRESSURE; BODY WEIGHT; CEREBROVASCULAR DISEASE; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DEMENTIA; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HEADACHE; HEART MUSCLE ISCHEMIA; HIP FRACTURE; HUMAN; HYPOMANIA; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAUSEA; REMISSION; SIDE EFFECT; SOMNOLENCE; SWEATING; TREMOR; VOMITING; XEROSTOMIA;

EID: 25844529324     PISSN: 14712318     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-4-11     Document Type: Article

References (35)

1. Alexopoulos GS, Borson S, Cuthbert BN, Devanand DP, Mulsant BH, Olin JT, Oslin DW: Assessment of late life depression. Biol Psychiatry 2002, 52:164.
2. Mulsant BH, Ganguli M: Epidemiology and diagnosis of depression in late life. J Clin Psychiatry 1999, 60(Suppl 20):9-15.
3. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Folstein MF: Depression and mortality in nursing homes. JAMA 1991, 265:993-996.
4. Beaumont G: The toxicity of antidepressants. Br J Psychiatry 1989, 154:454-458.
5. Hale AS: New antidepressants: use in high-risk patients. J Clin Psychiatry 1993, 54(Suppl):61-70.
6. Steffens DC, Krishnan KR, Helms MJ: Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta- analysis. Depress Anxiety 1997, 6:10-18.
7. Wong DT, Bymaster FP: Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype? Prog Drug Res 2002, 58:169-222.
8. Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA: Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002, 63:308-315.
9. Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA: Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002, 36:383-390.
10. Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA: Duloxetine in the treatment of major depressive disorder: a double- blind clinical trial. J Clin Psychiatry 2002, 63:225-231.
11. Nemeroff CB, Schatzberg AF, Goldstein DJ, Detke MJ, Mallinckrodt C, Lu Y, Tran PV: Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 2002, 36:106-132.
12. Nelson JC, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Kennedy JS: Duloxetine for the treatment of major depressive disorder in mature and elderly patients. Am J Geriatr Psychiatry 2004 in press.
13. Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF III, Alexopoulos GS, Bruce ML, Conwell Y, Katz IR, Meyers BS, Morrison MF, Mossey J, Niederehe G, Parmelee P: Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 1997, 278:1186-1190.
14. Old Age Depression Interest Group (OADIG): How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 1993, 162:175-182.
15. American Psychiatric Association: Diagnostic and statistical manual of mental disorders 4th edition. Washington, DC: American Psychiatric Association; 1994.
16. Guy W: ECDEU assessment manual for psychopharmacology, revised 1976 Rockville, MD: National Institutes of Mental Health; 1976.
17. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
18. Beck AT: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
19. Leon AC, Shear MK, Portera L, Klerman GL: Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol 1992, 27:78-82.
20. Thompson WL, Brunelle RL, Enas GG, Simpson PJ, Walker RL: Routine laboratory tests in clinical trials. Eli Lilly and Company, Indianapolis, IN; 1990:1-63. data on file
21. Eli Lilly and Company. 2002. data on file
22. Moss AJ: Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993, 72:23B-25B.
23. Thase ME: Methodology to measure onset of action. J Clin Psychiatry 2001, 62(Suppl 15):18-21.
24. Bondareff W, Alpert M, Friedhoff AJ, Richter EM, Clary CM, Batzar E: Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000, 157:729-736.
25. Bakish D: New standard of depression treatment: remission and full recovery. J Clin Psychiatry 2001, 62(Suppl 26):5-9.
26. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A: Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995, 25:1171-1180.
27. Baldwin RC: Poor prognosis of depression in elderly people: causes and actions. Ann Med 2000, 32:252-256.
28. Feighner JP, Cohn JB: Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985, 46:20-25.
29. Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctot KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH: The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 1997, 46:191-217.
30. von Moltke LL, Greenblatt DJ, Shader RI: Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications. Clin Pharmacokinet 1993, 24:141-160.
31. Glassman AH, Rodriguez AI, Shapiro PA: The use of antidepressant drugs in patients with heart disease. J Clin Psychiatry 1998, 59(Suppl 10):16-21.
32. Weber E, Stack J, Pollock BG, Mulsant B, Begley A, Mazumdar S, Reynolds CF III: Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial. Am J Geriatr Psychiatry 2000, 8:245-250.
33. Rigler SK, Webb MJ, Redford L, Brown EF, Zhou J, Wallace D: Weight outcomes among antidepressant users in nursing facilities. J Am Geriatr Soc 2001, 49:49-55.
34. Cohen LJ: Principles to optimize drug treatment in the depressed elderly: practical pharmacokinetics and drug interactions. Geriatrics 1995, 50(Suppl 1):S32-S40.
35. Beaumont G, Baldwin D, Lader M: A criticism of the practice of prescribing subtherapeutic doses of antidepressants for the treatment of depression. Hum Psychopharmacol 1996, 11:283-291.